Synthetic Biology Market Size Share - Emerging Evolution, Advancement, Industry Trends and Forecast 2018 - 2026

Synthetic Biology Market: Effect and Growth
Factors Research and Projection 2018-2026
Synthetic Biology Market, by Product Type (Oligonucleotides, Enzymes,
Cloning and Assembly Kits, Xeno-nucleic Acids (XNA) and Chassis Organism),
by Technology (Gene Synthesis, Next-generation Sequencing, Cloning and
Sequencing, Bioinformatics, Microfluidics, Nanotechnology, Site-saturation
Mutagenesis, and Mathematical Modeling), by Application (Medical Applications
(Drug Discovery & Therapeutics, and Artificial Tissue & Tissue Regeneration),
Industrial Applications (Biomaterials & Green Chemicals, Industrial Enzymes
and Biofuels & Renewable Energy), Environmental Applications (Bioremediation
and Whole-cell Biosensors)), and by Region (North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and
Opportunity Analysis, 2018-2026
Synthetic biology involves the design and construction of entirely new biological systems from
standardized genetic components, together with the essential redesign of existing life for new purposes.
Synthetic biology is extensively used in medical and pharmaceuticals field to produce and manufacture
improved biological drugs and systems to meet various challenges in the healthcare sector. Synthetic
biology offers various opportunities in the field of healthcare such as recreating highly complex
pathways, DNA sequences, and natural biological systems.
The Global Synthetic Biology Market size is estimated to be valued at US$ 6.09 billion in 2018, and
is expected to witness a CAGR of 33.9% during the forecast period (2018–2026).
Market Dynamics
Furthermore, growing research and development (R&D) activities to develop new technologies in
synthetic biology by government and private organizations and increasing demand for efficient
alternative therapy to design and market active pharmaceutical ingredients (APIs) in drug diagnosis and
therapeutics are other growth factors, which will drive the synthetic biology market growth.
Synthetic biology is majorly used in applications such as bioremediation, gene synthesis, industrial
enzyme production, drug discovery, therapeutics, and green chemicals, among others. However,
utilization of these applications is increasing concern regarding the risk and ethical issues associated
with synthetic biology, which include off-target mutation development, environmental misbalance, and
various other illegal usage of DNA sequencing.
Growing Research and Development (R&D) Funding and Rising Number of Synthetic Biology
Start-ups are expected to propel Growth of the Synthetic Biology Market
Growing investment/funding from companies in the branch of synthetic biology offers lucrative
opportunity to develop products such as consumer goods, bioengineered medicines, and industrial
chemicals. According to SynBioBeta data finding, January 2018, 50 companies including public and
private companies raised over US$ 1.7 billion for the development of innovative synthetic biology
technologies. Furthermore, according to the finding, the number of synthetic biology-based companies
is growing significantly. According to same source, in 2013, total number of synthetic biology
companies worldwide were 293, which increased to 346 (2014), 387 (2015), and 411 (2016).
Wide Range of Synthetic Biology Applications
Synthetic biology offers high efficiency to re-engineer and design the artificial bimolecular components
and biomaterials, which are majorly adopted in several biological, industrial, and environmental
applications such as gene engineering, drug discovery & therapeutics, novel protein synthesis, artificial
tissue regeneration, biofuels, industrial enzymes, bioremediation, and green chemicals.
In recent times, synthetic biology is tested to be used for storage of digital data. DNA offers potential to
store the massive amount of digital data, allowing to store one million times more dense information
than flash drives, and this data stored in DNA can be preserved for over 1,000 years. Furthermore, it is
also easier to prevent or detect the attempt to modify the stored data in the DNA. Currently, various
research and possible attempts are ongoing to commercialize this technology.
Ask For Sample Copy Of This Report : https://www.coherentmarketinsights.com/insight/requestsample/112
For instance, in September 2018, the Arch Mission Foundation partnered with Microsoft, University of
Washington, and Twist Bioscience to archive 10,000 crowd sourced images and full text of 20
important books, among others, in Astrobotic’s 2020 mission to the moon. DNA-based data storage
allows data to be encoded into billions of synthetic DNA molecules and encapsulated for long-term
preservation.
Among geographical region, Asia Pacific is expected to show conducive environment for growth of the
synthetic biology market, owing to expanding healthcare infrastructure, rising concerns related to fuel
consumption, growing government support, and engagement of key players in this region.
For instance, in June 2018, National Research Foundation (NRF) funded an amount of US$ 25 million
for five-year national synthetic biology R&D program, under the leadership of Prof Chua Nam Hai: a
renowned expert in plant biology and biotechnology; to bring advancement in synthetic biology
research in Singapore. In September 2018, Thermo Fisher Scientific initiated to sell its portfolio of
Invitrogen GeneArt products and services, including gene synthesis and genome editing products in
China.
Key players operating in the global synthetic biology market includes Thermo Fisher Scientific Inc.,
Twist Bioscience Corporation, Genscript Biotech Corporation, Codexis, Inc., Amyris, Inc., Danaher
Corporation (Integrated DNA Technologies, Inc.), EnBiotix, Inc., Evonetix Ltd., Ginkgo Bioworks,
Inc., and Prokarium.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]

Synthetic biology involves the design and construction of entirely new biological systems from standardized genetic components, together with the essential redesign of existing life for new purposes. Synthetic biology is extensively used in medical and pharmaceuticals field to produce and manufacture improved biological drugs and systems to meet various challenges in the healthcare sector.

Download Report